CELSIUS HOLDINGS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Celsius Holdings, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CELH

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Celsius Holdings, Inc. (NASDAQ: CELH) failed to manage Celsius in an acceptable manner, breaching their fiduciary duties to Celsius, and whether Celsius and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

Scott+Scott Attorneys at Law LLP, an international securities and consumer rights litigation firm, is investigating whether the directors of Celsius Holdings, Inc. (NASDAQ: CELH) breached their fiduciary duties to Celsius’s shareholders.

Share

• On June 4, 2026, the Office of the Texas Attorney General announced an investigation into Celsius for putting children at risk by deceptively marketing energy drinks to children.
• If you own Celsius common stock, join our investigation on behalf of Celsius and its shareholders by filling out the form below.

If you own Celsius common stock and you wish to discuss this investigation—at no cost for you—please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About this investigation – FAQ:

Q1: What is this ongoing investigation into Celsius about?

A: According to our investigation, owners of Celsius common stock have been impacted by the company’s misleading and dangerous marketing of its energy drink products to children. Scott+Scott has a decades-long track record in fighting for corporate governance and monetary recoveries on behalf of companies and their shareholders.

Q2: How does this Scott+Scott investigation work?

A: Joining our investigation is easy and at no cost for you. By filling out the form below, we will let you know your rights as a Celsius shareholder, and how the process works and what you can expect. If you currently own Celsius Biologics stock, we look forward to hearing from you.

To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com.

Attorney Advertising